Nuvation Bio Inc. (NUVB) Tops Q3 EPS by 1c, Beats on Revenue

Nuvation Bio Inc. (NYSE: NUVB) reported Q3 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $13.12 million versus the consensus estimate of $6.8 million.

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Trilogy Metals closes $35.6M investment from U.S. Department of War
• AstraZeneca's camizestrant fails primary endpoint in breast cancer trial